Dexcom (DXCM) Cash & Equivalents Growth (3y) (2013 - 2026)
Dexcom (DXCM) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 32.23% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.57% |
| Mar 31, 2026 | 21.52% |
| Dec 31, 2025 | 12.63% |
| Sep 30, 2025 | 25.30% |
| Jun 30, 2025 | 16.37% |
| Mar 31, 2025 | 8.12% |
| Dec 31, 2024 | -49.67% |
| Sep 30, 2024 | -24.52% |
| Jun 30, 2024 | -6.76% |
| Mar 31, 2024 | 5.07% |
| Dec 31, 2023 | -11.52% |
| Sep 30, 2023 | -1.50% |
| Jun 30, 2023 | 31.12% |
| Mar 31, 2023 | 2.15% |
| Dec 31, 2022 | 12.91% |
| Sep 30, 2022 | 20.84% |
| Jun 30, 2022 | 1.22% |
| Mar 31, 2022 | -17.71% |
| Dec 31, 2021 | -2.54% |
| Sep 30, 2021 | 57.82% |